64365-502 : Targretin 75 mg Oral Capsule
NDC: | 64365-502 |
Labeler: | Cardinal Health |
Drug Name: | Targretin |
Rev. Date: |
Appearance:
Markings: | Targretin |
Shapes: |
Oval |
Colors: |
White |
Size (mm): | 19 |
Segments: * | 1 |
* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines. |
Active Ingredients:
- Bexarotene
Inactive Ingredients:
- Polyethylene Glycol 400
- Polysorbate 20
- Povidone
- Butylated Hydroxyanisole
- Gelatin
- Sorbitol Special-glycerin Blend
- Titanium Dioxide
Related Products:
Based on records with the same trade name.- 0187-5525 Targretin 1 g/100g Topical Gel by Valeant Pharmaceuticals North America LLC
- 0187-5526 Targretin 75 mg/1 Oral Capsule, Liquid Filled by Valeant Pharmaceuticals North America LLC
- 62856-602 Targretin 75 mg Oral Capsule by Eisai Inc.
- 62856-604 Targretin 1 g/100g Topical Gel by Eisai Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 64363-0045Next: 64365-505 >
Related Discussions:
Bexarotene for Alzheimer's
Hi - has anyone else heard about the research being done on Bexarotene as a viable Alzheimer's treatment? Apparently... 4 replies
Hi - has anyone else heard about the research being done on Bexarotene as a viable Alzheimer's treatment? Apparently... 4 replies
Targretin for Cutaneous T Cell Lymphoma
My husband has CTCL and is being told to take Targretin. Can anyone tell me if they have taken it and what side effects ... 2 replies
My husband has CTCL and is being told to take Targretin. Can anyone tell me if they have taken it and what side effects ... 2 replies
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.